FOCUS BUSINESS NEWS


g


The OLED effect Coherent’s excess of $2 billion in annual orders were coupled with net sales of $1.72 billion and a net income of $207.1 million for its fiscal year ending 30 September 2017, a 101 per cent and 137 per cent increase respectively compared to its previous year. The dramatic increases reflect Coherent’s $942 million acquisition of industrial laser manufacturer Rofin- Sinar Technologies in November last year, in addition to strong performance in the microelectronics sector due to the continuing growth of OLED technology. The figures were announced after the


closing of the Coherent’s fourth quarter, for which it posted net sales of $490.3 million and a net income of $73.8 million, increases of 97 per cent and 140 per cent year-over-year, and 5.6 per cent and 20.7 per cent compared to its third-quarter results. The largest portion of sales were of


laser technologies for microelectronics fabrication, thanks to sustained strength


in OLED deployment and service, high semiconductor capital expenditure spending and a modest rebound in advanced packaging. Materials processing orders were also impressive, having grown dramatically due to both organic growth and Coherent’s acquisition of Rofin. Significant sales for OEM instrumentation were recorded as well, as growth in the core diagnostic and therapeutic space was complemented by organic and acquisitive growth in the aerospace and defence market.


Semiconductor success Jenoptik’s record €576.2 million order intake for the first nine months of the year was spurred by continued growth in solutions for the semiconductor equipment industry, as well as growth in the healthcare and industry sector. The group’s revenue therefore rose to €526.8 million in the first nine months, a 7.0 per cent increase year-over-year, with revenue increasing 7.7 per cent year-over-year in


NEWS FROM SPECTARIS By Dr Wenko Süptitz, head of photonics


Photonics takeaways from the Medica trade fair


M


edica, one of the largest annual exhibitions for the


medical industry, took place in Düsseldorf in November. The trade show figures are impressive – and tiring for the feet! Some 5,000 exhibitors from 70 nations presented their products in 17 exhibition halls. By comparison, the largest photonics fair in Europe, Laser World of Photonics in Munich, has some 1,300 exhibitors from 40 countries in five exhibition halls.


Indeed, medical technology


(medtec) is one of the most interesting applications for the photonics industry. With in-vitro optical diagnostics, endoscopy, microscopy, medical lasers and image processing there is a whole range of photonic technologies at one’s disposal. The trend towards the digitisation of medical technologies also fits well with


photonics, which was also made clear during the recent Spectaris forum ‘Photonik 4.0 – Optical Health Technologies’ in Berlin. Optical image processing, point of care and telemedicine are the hot topics where photonics is an integral part of the new digital era in hospitals and doctors’ offices. On the patient side, there


are a number of factors driving growth in the health industry and its suppliers. These include a higher proportion of the global population that can afford medical treatment; the ageing population, not only in western countries; and an increase in the number of people who are spending money to stay healthy. But there are also reasons


Extensive medical device regulations… turn every product launch into a test of strength and patience between innovators and regulators


22 Electro Optics December 2017/January 2018 Americas


Europe EMEA


Germany 9.3%


UK


France 3.8%


USA 38.8%


Italy 3.2%


3.8%


Israel 1.1%


Ireland 4.1%


Switzerland 1.5%


China 12.2%


Korea 1.4%


Asia Pacific


the third quarter alone. On a regional level, growth momentum came from abroad, particularly from the Americas, where initial nine-month revenue increased by 34.9 per cent year-over-year to €120 million (from €89 million previously). Overall the share of revenue generated abroad rose to 71.3 per cent, up from 65.3 per cent last year. The group’s optics and life science segment posted a strong 16.3 per cent increase in revenue for the first nine months to €191.3 million (from €164.5 million previously). This performance is being driven by the continued success of optical systems for the semiconductor equipment industry, the group reported. On the back of strong demand, the


healthcare and industry business segment earnings before interest and tax also improved significantly by 50.6 per cent to €36.9 million (previously €24.5 million). Order intake rose sharply as well by 29.4 per cent to €222.8 million (up from €172.2 million).


Japan 5.2%


The countries suppliers for medtec solutions should look for: the world market for medical technologies by region Source: Spectaris 2016 (calculation based on GTAI data, US Economic Service and Eurostat)


why medtec is well-known as being a difficult market for suppliers. There is a strong price pressure that has come as a result of shrinking public budgets. And, companies that try to escape from the price pressure with innovative products face an even higher hurdle: Extensive medical device regulations, which turn every product launch into a test of strength and patience


between innovators and regulators. Only those companies that


master the regulations barrier will survive in the long run. At Medica this was one of the talking points during a four-day long forum organised by Spectaris, where a large number of experts joined sessions covering the latest developments in medical device regulations.


@electrooptics | www.electrooptics.com


Canada 0.7%


Brazil 0.8%


Mexico 4.9%


Taiwan 1%


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56